Uray IP - Search Results

1

Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha.

Srinivas H, Xia D, Moore NL, Uray IP, Kim H, Ma L, Weigel NL, Brown PH, Kurie JM. Srinivas H, et al. Among authors: uray ip. Biochem J. 2006 May 1;395(3):653-62. doi: 10.1042/BJ20051794. Biochem J. 2006. PMID: 16417524 Free PMC article.

2

Prevention of breast cancer: current state of the science and future opportunities.

Uray IP, Brown PH. Uray IP, et al. Expert Opin Investig Drugs. 2006 Dec;15(12):1583-600. doi: 10.1517/13543784.15.12.1583. Expert Opin Investig Drugs. 2006. PMID: 17107283 Review.

3

Rexinoid-induced expression of IGFBP-6 requires RARbeta-dependent permissive cooperation of retinoid receptors and AP-1.

Uray IP, Shen Q, Seo HS, Kim H, Lamph WW, Bissonnette RP, Brown PH. Uray IP, et al. J Biol Chem. 2009 Jan 2;284(1):345-353. doi: 10.1074/jbc.M804721200. Epub 2008 Oct 28. J Biol Chem. 2009. PMID: 18957410 Free PMC article.

4

Chemoprevention of hormone receptor-negative breast cancer: new approaches needed.

Uray IP, Brown PH. Uray IP, et al. Recent Results Cancer Res. 2011;188:147-62. doi: 10.1007/978-3-642-10858-7_13. Recent Results Cancer Res. 2011. PMID: 21253797 Free PMC article. Review.

5

Retinoids and rexinoids in cancer prevention: from laboratory to clinic.

Uray IP, Dmitrovsky E, Brown PH. Uray IP, et al. Semin Oncol. 2016 Feb;43(1):49-64. doi: 10.1053/j.seminoncol.2015.09.002. Epub 2015 Sep 25. Semin Oncol. 2016. PMID: 26970124 Free PMC article. Review.

6

Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays.

Kim HT, Kong G, Denardo D, Li Y, Uray I, Pal S, Mohsin S, Hilsenbeck SG, Bissonnette R, Lamph WW, Johnson K, Brown PH. Kim HT, et al. Cancer Res. 2006 Dec 15;66(24):12009-18. doi: 10.1158/0008-5472.CAN-05-2515. Cancer Res. 2006. PMID: 17178900

7

Cancer-preventive rexinoid modulates neutral lipid contents of mammary epithelial cells through a peroxisome proliferator-activated receptor γ-dependent mechanism.

Uray IP, Rodenberg JM, Bissonnette RP, Brown PH, Mancini MA. Uray IP, et al. Mol Pharmacol. 2012 Feb;81(2):228-38. doi: 10.1124/mol.111.072967. Epub 2011 Nov 3. Mol Pharmacol. 2012. PMID: 22053058 Free PMC article.

8

SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).

Wang C, Uray IP, Mazumdar A, Mayer JA, Brown PH. Wang C, et al. Among authors: uray ip. Breast Cancer Res Treat. 2012 Jul;134(1):101-15. doi: 10.1007/s10549-011-1925-0. Epub 2012 Jan 3. Breast Cancer Res Treat. 2012. PMID: 22212555 Free PMC article.

9

The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.

Shen Q, Uray IP, Li Y, Krisko TI, Strecker TE, Kim HT, Brown PH. Shen Q, et al. Among authors: uray ip. Oncogene. 2008 Jan 10;27(3):366-77. doi: 10.1038/sj.onc.1210643. Epub 2007 Jul 16. Oncogene. 2008. PMID: 17637753

10

The AP-1 transcription factor regulates postnatal mammary gland development.

Shen Q, Zhang Y, Uray IP, Hill JL, Kim HT, Lu C, Young MR, Gunther EJ, Hilsenbeck SG, Chodosh LA, Colburn NH, Brown PH. Shen Q, et al. Among authors: uray ip. Dev Biol. 2006 Jul 15;295(2):589-603. doi: 10.1016/j.ydbio.2006.03.042. Epub 2006 Apr 4. Dev Biol. 2006. PMID: 16678816 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters